Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered Komagataella phaffii

Mostrar otras versiones (1)

Prevention of COVID-19 on a global scale will require the continued development of high-volume, low-cost platforms for the manufacturing of vaccines to supply on-going demand. Vaccine candidates based on recombinant protein subunits remain important because they can be manufactured at low costs in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalvie, Neil C., Biedermann, Andrew M., Rodriguez-Aponte, Sergio A., Naranjo, Christopher A., Rao, Harish D., Rajurkar, Meghraj P., Lothe, Rakesh R., Shaligram, Umesh S., Johnston, Ryan S., Crowell, Laura E., Castelino, Seraphin, Tracey, Mary Kate, Whittaker, Charles A., Love, J. Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057236/
https://www.ncbi.nlm.nih.gov/pubmed/33880471
http://dx.doi.org/10.1101/2021.04.15.440035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057236/
https://www.ncbi.nlm.nih.gov/pubmed/33880471
http://dx.doi.org/10.1101/2021.04.15.440035

Ejemplares similares